
Xtant Medical Holdings XTNT
$ 0.58
3.57%
Annual report 2025
added 03-31-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSE AMERICAN |
Shares |
140 M |
Market Cap[1] |
$ 80.9 M |
EBITDA (LTM) |
$ 3.14 M |
P/E (LTM) |
-17.33 |
P/S (LTM) |
0.57 |
EPS (LTM) |
-0.03 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 11.42 | 3.63 % | $ 409 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 26.23 | 2.62 % | $ 222 M | NYSE American | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.45 | 1.71 % | $ 129 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.14 | -0.93 % | $ 1.3 M | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 45.59 | -16.87 % | $ 1.34 B | NYSE,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 11.03 | -1.34 % | $ 312 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.62 | 0.47 % | $ 38.6 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 56.96 | -3.57 % | $ 3.11 B | Nasdaq Global Select Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.05 | -3.69 % | $ 17.8 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.18 | 2.5 % | $ 380 M | Nasdaq Global Select Market,SPB | ||
|
Insulet Corporation
PODD
|
$ 169.04 | -1.37 % | $ 11.9 B | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 5.0 | 2.99 % | $ 1.06 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Sintx Technologies
SINT
|
$ 2.39 | -1.24 % | $ 6.63 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 91.11 | 0.56 % | $ 12.3 B | NYSE,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 36.09 | 0.59 % | $ 1.12 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 95.4 | -1.73 % | $ 3.24 B | Nasdaq Global Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.18 | -3.47 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 86.99 | 3.62 % | $ 3.02 B | NYSE,SPB | ||
|
Stryker Corporation
SYK
|
$ 295.85 | 1.71 % | $ 113 B | NYSE,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 83.06 | -0.32 % | $ 48.6 B | NYSE,SPB | ||
|
LENSAR
LNSR
|
$ 5.51 | -0.9 % | $ 65.9 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.29 | -3.38 % | $ 52.5 M | Nasdaq Global Select Market | ||
|
MiMedx Group
MDXG
|
$ 3.7 | 2.49 % | $ 547 M | Nasdaq Global Select Market | ||
|
Myomo
MYO
|
$ 0.87 | 0.15 % | $ 36.4 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.